Lexicon Pharmaceuticals Inc (LXRX) Insider Trading
- $304,386,162.43
- $551,529.66
- Feb. 25, 2026
- Public Equities L.P. Invus
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Nov. 26, 2014 | Director | 149,253,731 | $1.01 | Buy | $150,746,268.31 | |
| Oct. 25, 2013 | CFO | 227,626 | $0.13 | Sell | $29,591.38 | |
| Oct. 9, 2013 | CFO | 83,281 | $0.19 | Sell | $15,823.39 | |
| July 9, 2013 | CFO | 88,235 | $0.11 | Sell | $9,705.85 | |
| June 27, 2013 | CEO | 160,000 | $0.13 | Sell | $20,800.00 | |
| June 18, 2013 | CEO | 220,000 | $0.18 | Sell | $39,600.00 | |
| June 7, 2013 | CEO | 170,000 | $0.19 | Sell | $32,300.00 | |
| Nov. 21, 2012 | CEO | 23,700 | $0.34 | Sell | $8,058.00 | |
| Oct. 23, 2012 | Director | 3,000,000 | $2.25 | Buy | $6,750,000.00 | |
| Oct. 3, 2012 | CEO | 25,000 | $0.30 | Sell | $7,500.00 |
Insiders are both buying and selling Lexicon Pharmaceuticals Inc stock.
The insider traders at Lexicon Pharmaceuticals Inc are: Public Equities L.P. Invus, Lonnel Coats, James F Tessmer, Raymond Debbane, Alexander Richard Walsh, International S.C.A. Artal, Jeffrey L Wade, Bryan A Kleinlein, Wendy Mcdermott, Christopher J Sobecki, C.V. Invus, Sam L Barker, and Alexander A Santini
The most active insider trader at Lexicon Pharmaceuticals Inc is Public Equities L.P. Invus with 15 trades.
James F Tessmer has sold the most Lexicon Pharmaceuticals Inc stock with a total value of $546,702.08.
International S.C.A. Artal has bought the most Lexicon Pharmaceuticals Inc stock with a total value of $342,361,028.31.
The most recent insider trade for Lexicon Pharmaceuticals Inc was on Feb. 25, 2026.
The single biggest insider buy for Lexicon Pharmaceuticals Inc was from International S.C.A. Artal with a total value of $150,746,268.31 on Nov. 26, 2014.
The single biggest insider sell for Lexicon Pharmaceuticals Inc was from James F Tessmer with a total value of $158,551.04 on March 15, 2021.